Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Phoenix Financial Ltd. | ITRN Ituran Location & Control Ltd. | 13G/A | 4.98% | Mar 12, 2024 | 2y |
| Lytton, Laurence W. | BFRI Biofrontera Inc. | 13G | 9.99% | Feb 20, 2024 | 2y |
| Orin Hirschman | BFRI Biofrontera Inc. | 13G | 9.9% | Feb 20, 2024 | 2y |
| ATS Brand Sdn Bhd. | XMAX XMax Inc. | 13G | 12.9% | Jan 23, 2024 | 2y |
| Hasson Heather L. | FIGS FIGS, Inc. | 13D/A | 9.55% | Mar 19, 2024 | 2y |
| Findell Capital Partners LP | OPRT Oportun Financial Corp | 13D/A | 7.7% | Mar 19, 2024 | 2y |
| Eugenio Santiago Clariond Reyes | BY Byline Bancorp, Inc. | 13G/A | 4.6% | Mar 19, 2024 | 2y |
| Spear Catherine Eva | FIGS FIGS, Inc. | 13D/A | 12.64% | Mar 19, 2024 | 2y |
| Pfizer Inc | HLN Haleon plc | 13D/A | 32% | Mar 19, 2024 | 2y |
| Leviticus Partners LP | FRSX Foresight Autonomous Holdings Ltd. | 13G/A | 5.97% | Mar 18, 2024 | 2y |
| Bertelsmann SE & Co. KGaA | AFYA Afya Ltd | 13D/A | 60.1% | Mar 18, 2024 | 2y |
| Leviticus Partners LP | HBIO Harvard Bioscience Inc | 13G | 5.32% | Mar 18, 2024 | 2y |
| BML Investment Partners, L.P. | CYT Cyteir Therapeutics, Inc. Common Stock | 13G/A | 10.6% | Mar 18, 2024 | 2y |
| Ted Karkus | PRPH ProPhase Labs, Inc. | 13D/A | 20.3% | Mar 17, 2024 | 2y |
| Beijing Zhenwei Qingfeng Economic Management Consulting Partnership (L.P.) | NAAS NaaS Technology Inc. | 13D/A | 9.86% | Mar 15, 2024 | 2y |
| Standard General L.P. | BALY Bally's Corp | 13D/A | 26.4% | Mar 15, 2024 | 2y |
| Charles F. Dolan | MSGE Madison Square Garden Entertainment Corp. | 13D/A | 9.3% | Mar 15, 2024 | 2y |
| Starboard Value LP | ALIT Alight, Inc. / Delaware | 13D/A | 7.3% | Mar 15, 2024 | 2y |
| Great Hill Equity Partners IV, L.P. | INTA Intapp, Inc. | 13D/A | 9.2% | Mar 15, 2024 | 2y |
| William J. Colombo | DKS Dick's Sporting Goods, Inc. | 13D/A | 13.77% | Mar 15, 2024 | 2y |
| Synchron | REEMF Rare Element Resources Ltd | 13D/A | 70.6% | Mar 15, 2024 | 2y |
| Jonathan H. Kaufman | LIPO Lipella Pharmaceuticals Inc. | 13D/A | 21% | Mar 15, 2024 | 2y |
| Fund 1 Investments, LLC | TLYS Tilly's, Inc. | 13D/A | 33.87% | Mar 15, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | BGC BGC Group, Inc. | 13G | 0.6% | Mar 14, 2024 | 2y |
| David Brody | XTIA XTI Aerospace, Inc. | 13D | 25.52% | Mar 12, 2024 | 2y |
| de Rothschild Robert | PNRG Primeenergy Resources Corp | 13D/A | 16.2% | Mar 12, 2024 | 2y |
| Philadelphia Financial Management of San Francisco, LLC | MCHB Mechanics Bancorp | 13G | 5.3% | Mar 11, 2024 | 2y |
| Quogue Capital LLC | IOVA Iovance Biotherapeutics, Inc. | 13D/A | 11.6% | Feb 20, 2024 | 2y |
| CONTINENTAL GENERAL INSURANCE CO | AMR Alpha Metallurgical Resources, Inc. | 13D/A | 10.7% | Nov 2, 2023 | 2y |
| Memphis Equity Ltd | SWVL Swvl Holdings Corp | 13D | 10.53% | Mar 31, 2022 | 2y |
| ICAHN CARL C | UAN Cvr Partners, LP | 13D | 36.8% | Mar 18, 2024 | 2y |
| Nirav Tolia | NXDR Nextdoor Holdings, Inc. | 13D/A | 13.2% | Mar 18, 2024 | 2y |
| ICAHN CARL C | CVI Cvr Energy Inc | 13D/A | 66.3% | Mar 18, 2024 | 2y |
| Cove Street Capital, LLC | TBRG TruBridge, Inc. | 13G | 5.06% | Mar 18, 2024 | 2y |
| Dmitry Genkin | XBIO Xenetic Biosciences, Inc. | 13D/A | 14% | Mar 18, 2024 | 2y |
| JAB BevCo B.V. | KDP Keurig Dr Pepper Inc. | 13D/A | 21% | Mar 15, 2024 | 2y |
| Saba Capital Management, L.P. | DSM Bny Mellon Strategic Municipal Bond Fund, Inc. | 13D/A | 6.23% | Mar 15, 2024 | 2y |
| Cano Health, Inc. | MSPR MSP Recovery, Inc. | 13D/A | 15.6% | Mar 14, 2024 | 2y |
| Saba Capital Management, L.P. | LGI Lazard Global Total Return & Income Fund Inc | 13D | 5.02% | Mar 14, 2024 | 2y |
| Corvex Management LP | MDU Mdu Resources Group Inc | 13D/A | 4.98% | Mar 14, 2024 | 2y |
| Dominion Capital LLC | HUBC Hub Cyber Security Ltd. | 13D | 4.6% | Mar 14, 2024 | 2y |
| NOVO HOLDINGS A/S | SPRB Spruce Biosciences, Inc. | 13D/A | 15.1% | Mar 14, 2024 | 2y |
| Topline Capital Management, LLC | ACCS ACCESS Newswire Inc. | 13G/A | 14.5% | Mar 14, 2024 | 2y |
| FS Capital Partners VI, LLC | ARHS Arhaus, Inc. | 13D/A | 0.47% | Mar 14, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | CLYM Climb Bio, Inc. | 13D/A | 47.5% | Mar 14, 2024 | 2y |
| CAS Investment Partners, LLC | CDLX Cardlytics, Inc. | 13D/A | 13.7% | Mar 14, 2024 | 2y |
| Pinetree Capital Ltd. | TBRG TruBridge, Inc. | 13D/A | 9.7% | Mar 14, 2024 | 2y |
| Saba Capital Management, L.P. | CPZ Calamos Long/Short Equity & Dynamic Income Trust | 13D | 5.07% | Mar 13, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | MYGN Myriad Genetics Inc | 13G | 4.7% | Mar 12, 2024 | 2y |
| D. E. Shaw & Co., L.P. | OPTU Optimum Communications, Inc. | 13G | 5% | Mar 8, 2024 | 2y |